Davar, D., Liu, Y., Laporte, J., Guha, P., Katz, S. C., Ghosh, C. C., . . . Murtha, T. D. Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases. BMJ Publishing Group.
Chicago Style (17th ed.) CitationDavar, Diwakar, et al. Subcutaneous Checkpoint Inhibition Is Equivalent to Systemic Delivery When Combined with Nelitolimod Delivered via Pressure-enabled Drug Delivery for Depletion of Intrahepatic Myeloid-derived Suppressor Cells and Control of Liver Metastases. BMJ Publishing Group.
MLA (9th ed.) CitationDavar, Diwakar, et al. Subcutaneous Checkpoint Inhibition Is Equivalent to Systemic Delivery When Combined with Nelitolimod Delivered via Pressure-enabled Drug Delivery for Depletion of Intrahepatic Myeloid-derived Suppressor Cells and Control of Liver Metastases. BMJ Publishing Group.